Bigul

Zydus Wellness Ltd - 531335 - Approval Of Specific Terms Of Issue Of Secured Non-Convertible Debentures.

Fund Raising Committee of the Issuer ('Committee') today pursuant to the meeting held at 1:00 p.m. approved the specific terms of the issue of rated, secured, listed, redeemable, non-convertible debentures ('Debentures') each having a face value of INR 10,00,000 (Indian Rupees Ten Lakh) of the aggregate nominal value up to INR 1500,00,00,000 (Indian Rupees One Thousand Five Hundred Crore), further to the resolution of the Board of Directors dated 6 December 2018 (intimation for which was made to the stock exchanges on 3 December 2018).
11-01-2019
Bigul

Zydus Wellness Ltd - 531335 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Zydus Wellness Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
05-01-2019
Bigul

Zydus Wellness Ltd - 531335 - Proceedings Of EOGM And Announcement Of Voting Results

Please find attached the proceedings of the EOGM along the announcement of voting results by the Chairman based on the report of Scrutinizer.
04-01-2019
Bigul

ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Credit Rating

We hereby inform that the Company has availed credit rating of 'CARE AA+; Stable from CARE Ratings Limited for proposed issue of Rs. 1,500/- Crore Secured Redeemable Non-Convertible Debentures (NCDs) of the Company. A copy of letter received from CARE Ratings Limited is enclosed. Please receive the same in order and bring the same to the notice of the members of the exchange and investors' at large.
01-01-2019
Bigul

ZYDUS WELLNESS LTD.-$ - 531335 - Corrigendum To The Notice Convening Extra Ordinary General Meeting

Corrigendum to the Notice convening Extra Ordinary General Meeting scheduled to be held on January 4, 2019 at 10:00 a.m. on Friday.
01-01-2019
Bigul

ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Credit Rating

We hereby inform that the Company has availed the credit rating of 'CRISIL AA+/Stable', (pronounced 'CRISIL double A plus rating with stable outlook) from CRISIL Limited for proposed issue of Rs. 1500/- Crores Secured Redeemable Non-Convertible Debentures (NCD) of the Company. A copy of letter received from CRISIL Limited is attached. Please receive the same in order and bring the same to the notice of the members of the exchange and the investors' at large.
29-12-2018
Bigul

Zydus Cadila gets USFDA nod to market generic drug for tapeworm infections

The company's product will be manufactured at Zydus group's formulations manufacturing facility at Ahmedabad
15-12-2018
Bigul

Advertisement Of Notice Of Extra Ordinary General Meeting And E-Voting Information.

Please find enclosed herewith the copies of Advertisement of Notice of Extra Ordinary General Meeting, and e-voting information published in the English and Gujarati editions of Financial Express on December 13, 2018.
13-12-2018
Bigul

Zydus Wellness jumps over 4% on CCI nod for Heinz deal

Shares of Zydus Wellness surged over 4 per cent as the Competition Commission of India has approved Zydus Cadila's deal to acquire Heinz India's consu
12-12-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Wellness' acquisition of Heinz India receives a nod from Competition Regulator
11-12-2018
Next Page
Close

Let's Open Free Demat Account